Anaesthetic experience with isolated limb perfusion with melphalan for melanoma

Perfusion

Volumn 11, Issue 5, 1996, Pages 395-399

  Kam, P C A ^a   Thompson, J F ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; MELPHALAN;

ADULT; AGED; ANESTHESIA; ARTICLE; EXTRACORPOREAL CIRCULATION; FEMALE; FLUID SHIFT; HUMAN; HYPERTHERMIC THERAPY; LIMB; LIMB PERFUSION; MAJOR CLINICAL STUDY; MELANOMA; PATIENT MONITORING; PRIORITY JOURNAL; VASCULARIZATION; VENOUS PRESSURE;

EID: 0029779247     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919601100507     Document Type: Article

References (11)

1. Kroon BBR. Regional isolated perfusion in melanoma of the limbs: accomplishments, unsolved problems, future. Eur J Surg Oncol 1988; 14: 101-10.
2. Stehlin JS. Hyperthermic perfusion with chemotherapy for cancer of the extremities. Surg Gynaecol Obstet 1969; 129: 305-8.
3. Thompson JF, Lai DTM, Ingvar C, Kam PCA. Maximizing efficacy and minimizing toxicity in isolated perfusion for melanoma. Melanoma Res 1994; 4(suppl. 1): 45-50.
4. Creech OJ. Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958; 148: 616-32.
5. Chang SY, Alberts DS, Farquar D, Melnick LR, Watson PD, Salmon SE. Hydrolysis and protein binding of melphalan. J Pharm Sci 1978; 67: 682-84.
6. Goldberg ME, Rosenblum HM, Seltzer JL, Rosato FE. Isolated regional perfusion: anaesthetic technique, monitoring and blood replacement. Can Anaesth Soc J 1984; 31: 552-58.
7. Crutchley PM, Kaplan JA, Waller JL, Young MR. Anesthesia for isolated hyperthermic limb perfusion. Anesthesiology 1982; 57: 228-30.
8. Klaase JM, Kroon BBR, Van Geel AN, Eggermont AMM, Franklin HR. Systemic leakage during isolated limb perfusion for melanoma. Br J Surg 1993; 80: 1124-26.
9. Krementz ET. Regional perfusion: current sophistication, what next? Cancer 1986; 57: 416-32.
10. Coates A, Abraham S, Kaye SB et al. On the receiving end - patient perception of the side effects of cancer chemotherapy. Eur J Cancer, Clin Oncol 1983; 19: 203-8.
11. Thompson JF, Malouf DJ, Merzliakov S. Kam PCA. Efficacy of single dose ondansetron in the prevention of post-operative nausea and vomiting following isolated limb perfusion with cytotoxic agents. Regional Cancer Treatment 1993; 4: 177-82.